These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 965092)

  • 1. Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.
    Dasgupta BR; Sugiyama H
    Infect Immun; 1976 Sep; 14(3):680-6. PubMed ID: 965092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.
    Dekleva ML; DasGupta BR
    Biochem Biophys Res Commun; 1989 Jul; 162(2):767-72. PubMed ID: 2667520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of intracellular type A botulinum neurotoxin.
    Krysinski EP; Sugiyama H
    Appl Environ Microbiol; 1981 Mar; 41(3):675-8. PubMed ID: 7013709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxin types A, B & E: pH induced difference spectra.
    Datta A; DasGupta BR
    Mol Cell Biochem; 1988 Jun; 81(2):187-94. PubMed ID: 3050452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and amino acid composition of type A botulinum neurotoxin.
    DasGupta BR; Sathyamoorthy V
    Toxicon; 1984; 22(3):415-24. PubMed ID: 6382680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial amino acid sequences of botulinum neurotoxins types B and E.
    Schmidt JJ; Sathyamoorthy V; DasGupta BR
    Arch Biochem Biophys; 1985 May; 238(2):544-8. PubMed ID: 3888113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of botulinum toxins in the absence of nicking.
    Ohishi I; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):402-7. PubMed ID: 19360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.
    Miyazaki S; Iwasaki M; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):395-401. PubMed ID: 892912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent structure of botulinum neurotoxin type B; location of sulfhydryl groups and disulfide bridge and identification of C-termini of light and heavy chains.
    Antharavally BS; DasGupta BR
    J Protein Chem; 1998 Jul; 17(5):417-28. PubMed ID: 9717738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a protease in natural activation of Clostridium botulinum neurotoxin.
    Das Gupta BR; Sugiyama H
    Infect Immun; 1972 Oct; 6(4):587-90. PubMed ID: 4564288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E.
    Sathyamoorthy V; DasGupta BR
    J Biol Chem; 1985 Sep; 260(19):10461-6. PubMed ID: 4030755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative molecular topography of botulinum neurotoxins from Clostridium butyricum and Clostridium botulinum type E.
    Singh BR; Giménez JA; DasGupta BR
    Biochim Biophys Acta; 1991 Mar; 1077(1):119-26. PubMed ID: 1901221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is formation of visible channels in a phospholipid bilayer by botulinum neurotoxin type B sensitive to its disulfide?
    Flicker PF; Robinson JP; DasGupta BR
    J Struct Biol; 1999 Dec; 128(3):297-304. PubMed ID: 10633069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity.
    Shone CC; Hambleton P; Melling J
    Eur J Biochem; 1985 Aug; 151(1):75-82. PubMed ID: 3896784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.
    Suzuki T; Kouguchi H; Watanabe T; Hasegawa K; Yoneyama T; Niwa K; Nishikawa A; Lee JC; Oguma K; Ohyama T
    Protein J; 2007 Apr; 26(3):173-81. PubMed ID: 17200883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxin type B (strain 657): partial sequence and similarity with tetanus toxin.
    Dasgupta BR; Datta A
    Biochimie; 1988 Jun; 70(6):811-7. PubMed ID: 3139097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated light chains of botulinum neurotoxins inhibit exocytosis. Studies in digitonin-permeabilized chromaffin cells.
    Bittner MA; DasGupta BR; Holz RW
    J Biol Chem; 1989 Jun; 264(18):10354-60. PubMed ID: 2732226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular dichroic and fluorescence spectroscopic study of the conformation of botulinum neurotoxin types A and E.
    Datta A; DasGupta BR
    Mol Cell Biochem; 1988 Feb; 79(2):153-9. PubMed ID: 3398838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.